Welltower Inc. HCN
No live quote for HCN yet.
- Analysts
- Hold
- Price target
- 62.72
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: hold
Hold
Price target (mean) 62.72
- Target (low)
- 54.00
- Target (mean)
- 62.72
- Target (high)
- 74.50
Ratings (0m) 22 5 buy · 14 hold · 3 sell
- Strong buy2
- Buy3
- Hold14
- Sell3
- Strong sell0
Next earnings
Consensus EPS estimate 0.40.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 23, 2017 | Evercore ISI Group | down | — | Underperform |
| Mar 19, 2017 | Morgan Stanley | up | — | Overweight |
| Jan 18, 2017 | SunTrust Robinson Humphrey | down | — | Hold |
| Jan 4, 2017 | Mitsubishi UFJ | up | — | Overweight |
| Dec 12, 2016 | Wells Fargo | down | — | Market Perform |
| Sep 13, 2016 | Stephens & Co. | init | — | Overweight |
News
Benzinga'a M&A Chatter for Wednesday August 22, 2012 
Morgan Keegan Analyzes Publicly Traded Healthcare REITs (HCP, HCN, VTR, NHP) 
HCN Stable in Dividend Payouts - Analyst Blog 
HCN Stable in Dividend Payouts - Analyst Blog - Strong Q4 for Health Care REIT - Analyst Blog
Strong Q4 for Health Care REIT - Analyst Blog
Your note
Sign in to keep a note on HCN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BACON KENNETH J | Director | Option Exercise | Feb 11, 2017 | 2,124 |
| BRINKER SCOTT M | Officer | Disposition (Non Open Market) | Dec 30, 2016 | 102,550 |
| DEROSA THOMAS J | Officer | Disposition (Non Open Market) | Jan 14, 2018 | 220,769 |
| DONAHUE JEFFREY H | Director | Option Exercise | Feb 11, 2017 | 36,715 |
| ESTES SCOTT A | Officer | Sale | Feb 28, 2017 | 117,607 |
| GOODEY JOHN | Officer | Disposition (Non Open Market) | Jan 14, 2018 | 38,175 |